Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 15:S0092-8674(25)00734-2.
doi: 10.1016/j.cell.2025.06.032. Online ahead of print.

Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1

Affiliations

Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1

Yunhui Ge et al. Cell. .

Abstract

Adequate delivery of thyroid hormones to the brain is crucial for normal neurological development. MCT8 and OATP1C1, two solute carrier (SLC) transporters, mediate the passage of thyroid hormones across the blood-brain barrier and into the central nervous system. Mutations in MCT8 result in Allan-Herndon-Dudley syndrome (AHDS), an X-linked birth defect characterized by neurodevelopmental impairments and peripheral hyperthyroidism, whereas OATP1C1 deficiency is linked to brain hypometabolism and progressive neurodegeneration. Here, we report cryoelectron microscopy (cryo-EM) structures of MCT8 and OATP1C1 bound with the active thyroid hormone triiodothyronine (T3) and the prohormone thyroxine (T4) at 2.9 and 2.3 Å resolutions, respectively. Combined with functional studies, we elucidate their distinct thyroid hormone recognition and transport mechanisms and explain disease mutations. Although extracellular allosteric sites are not a common feature of SLC transporters, we identify one in OATP1C1. Collectively, these findings illuminate key aspects of thyroid hormone transport, a fundamental process in development and disease.

Keywords: AHDS; Allan-Herndon-Dudley syndrome; MCT8; OATP1C1; SLC transporters; T3; T4; blood-brain barrier; thyroid hormones; thyroxine.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Mullur R, Liu Y-Y, and Brent GA (2014). Thyroid Hormone Regulation of Metabolism. Physiological Reviews 94, 355–382. 10.1152/physrev.00030.2013. - DOI - PMC - PubMed
    1. Yen PM (2001). Physiological and molecular basis of thyroid hormone action. Physiol Rev 81, 1097–1142. 10.1152/physrev.2001.81.3.1097. - DOI - PubMed
    1. Groeneweg S, van Geest FS, Peeters RP, Heuer H, and Visser WE (2020). Thyroid Hormone Transporters. Endocrine Reviews 41, 146–201. 10.1210/endrev/bnz008. - DOI - PubMed
    1. Friesema ECH, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, and Visser TJ (2003). Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278, 40128–40135. 10.1074/jbc.M300909200. - DOI - PubMed
    1. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, and Meier PJ (2002). Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol 16, 2283–2296. 10.1210/me.2001-0309. - DOI - PubMed

LinkOut - more resources